SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 17, 2011
AXIUS INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Nevada |
| 000-54400 |
| 27-3574086 |
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (I.R.S. Employer Identification No.) |
|
6A Easa Al Gurg Tower, 6th Floor, Baiyas Road, P.O.Box 186549, Dubai UAE |
Address of principal executive offices |
Registrants telephone number, including area code: 00971 44475722
|
|
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
. Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)
. Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
. Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
. Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 3.02 Unregistered Sales of Equity Securities
On or about June 17, 2011 AXIUS INC. (hereinafter the Company) in accordance with Board of Directors resolution issued an aggregate of 2,950,000 shares of its common stock to those person and or firms listed below.
The issuance of such shares was exempt from registration in accordance with Section 4(2) of the Securities Act of 1933 as a transaction by an Issuer not involved in a public offering.
The 2,950,000 restricted shares of common stock were issued as follows.
Names | Number of Restricted Shares |
1. Dr. Jules Nabet | 500,000 |
2. Roland Kaufman | 1,000,000 |
3. John Figliolini | 1,000,000 |
4. Dr. Kathy Gohar | 250,000 |
5. Gary Wolff | 100,000 |
6. Yann Mrazek | 100,000 |
The Company is not aware of any arrangements which may at a subsequent date, result in a change in control.
There is no new material relationship between the Company or its affiliates and any of the parties other than as indicated herein.
1. Managing Director of Companys wholly owned subsidiary Dr. Jules Nabet Cosmetics, Inc.
2. Company President and CEO
3. Company CFO, COO, and Secretary Director
4. Medical Consultant
5. Company Securities Counsel
6. Company Legal Counsel in Dubai, UAE
Item 9.01 Financial Statements and Exhibits
(c)Exhibits - None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AXIUS INC.
/s/ Roland Kaufman
Roland Kaufman
President, CEO and Director